(Q62110561)

English

Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

clinical trial

In more languages

default for all languages

No label defined

No description defined

Statements

0 references

A PHASE I-II TRIAL OF MUROMONAB (OKT-3) WITH LOW-DOSE CYCLOPHOSPHAMIDE (English)

0 references

United States of America

0 references

June 1991

0 references

research intervention

(RS)-cyclophosphamide

0 references

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

St. Vincent Medical Center

0 references

research subject recruitment status

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110561&oldid=2149433568"